Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Bradenton, FL
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Hialeah, FL
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Saint Petersburg, FL
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Fort Worth, TX
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Lincoln, CA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Lincoln, CA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
San Diego, CA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Fort Myers, FL
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Meridian, ID
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Meridian, ID
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Marrero, LA
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Marrero, LA
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Winston-Salem, NC
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Mount Pleasant, SC
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Pearland, TX
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Pearland, TX
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
San Antonio, TX
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Kenosha, WI
A 6 Month Safety Extension Study of MBGS205
A 6 Month, Double-blind Safety Extension Study of MBGS205
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Kenosha, WI
Click here to add this to my saved trials
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Laguna Hills, CA
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Covington, KY
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Covington, KY
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Budapest,
Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling
Updated: 12/31/1969
mi
from
Budapest,
Click here to add this to my saved trials
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Status: Enrolling
Updated:  12/31/1969
Oakland
mi
from
Oakland, CA
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Status: Enrolling
Updated: 12/31/1969
Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Hyperthyroid Follow-Up Study
Hyperthyroid Follow-Up Study
Status: Enrolling
Updated:  12/31/1969
Social and Scientific Systems, Inc.
mi
from
Durham, NC
Hyperthyroid Follow-Up Study
Hyperthyroid Follow-Up Study
Status: Enrolling
Updated: 12/31/1969
Social and Scientific Systems, Inc.
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Providence Clinical Research
mi
from
North Hollywood, CA
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Providence Clinical Research
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Crescent City Clinical Research Center
mi
from
Metairie, LA
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Crescent City Clinical Research Center
mi
from
Metairie, LA
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
University Of Kentucky School of Medicine
mi
from
Lexington, KY
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
University Of Kentucky School of Medicine
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic - PPDS
mi
from
Rochester, MN
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic - PPDS
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research (NOCCR) - Knoxville
mi
from
Knoxville, TN
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research (NOCCR) - Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated:  12/31/1969
CHU de Quebec-Universite Laval
mi
from
Quebec,
Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Status: Enrolling
Updated: 12/31/1969
CHU de Quebec-Universite Laval
mi
from
Quebec,
Click here to add this to my saved trials
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
Role of EPA and DHA in Fish Oil on Inflammation and Lipoprotein Metabolism
Status: Enrolling
Updated:  12/31/1969
Jean Mayer Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
Role of EPA and DHA in Fish Oil on Inflammation and Lipoprotein Metabolism
Status: Enrolling
Updated: 12/31/1969
Jean Mayer Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism
Single-Arm, Non-inferiority Study of Omission of Intraoperative Intact Parathyroid Hormone (PTH) During Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism
Single-Arm, Non-inferiority Study of Omission of Intraoperative Intact Parathyroid Hormone (PTH) During Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Effect of Dried Fruit on Cardiometabolic Risk Factors
The Effect of Bioactives in Dried Plums, Figs, Dates, and Raisins Compared With a High Carbohydrate Snack on Risk Factors for Cardiometabolic Disease
Status: Enrolling
Updated:  12/31/1969
Penn State University
mi
from
University Park, PA
Effect of Dried Fruit on Cardiometabolic Risk Factors
The Effect of Bioactives in Dried Plums, Figs, Dates, and Raisins Compared With a High Carbohydrate Snack on Risk Factors for Cardiometabolic Disease
Status: Enrolling
Updated: 12/31/1969
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Treatment Development of Triheptanoin (G1D)
Treatment Development of Triheptanoin (C7) for Glucose Transporter Type I Deficiency (G1D): A Phase I Maximum Tolerable Dose Trial
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Treatment Development of Triheptanoin (G1D)
Treatment Development of Triheptanoin (C7) for Glucose Transporter Type I Deficiency (G1D): A Phase I Maximum Tolerable Dose Trial
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials